重大事件
即時報告
8-K
2026-06-17
Liquidia Corp 提交8-K報告 披露股東投票結果
AI 繁中摘要
Liquidia Corp 於 2026 年 6 月 17 日向 SEC 提交了一份 8-K 即時報告，報告期為前一天（2026 年 6 月 16 日）。📄
本次申報主要涵蓋兩項內容：
- **Item 5.07**：股東投票事項的提交結果。公司當日舉行了
展開英文正文
EDGAR Filing Documents for 0001104659-26-075177 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001104659-26-075177 Filing Date 2026-06-17 Accepted 2026-06-17 16:31:46 Documents 11 Period of Report 2026-06-16 Items Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K tm2618171d1_8k.htm iXBRL 8-K 35570 Complete submission text file 0001104659-26-075177.txt 200912 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA lqda-20260616.xsd EX-101.SCH 3014 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20260616_lab.xml EX-101.LAB 34239 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20260616_pre.xml EX-101.PRE 22358 14 EXTRACTED XBRL INSTANCE DOCUMENT tm2618171d1_8k_htm.xml XML 3180 Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400 Liquidia Corp (Filer) CIK: 0001819576 (see all company filings) EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 261098988 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)